Cogent Biosciences Inc (COGT)

EBITDA Growth

-33.34%

TTM · Period ending:

COGT logo

COGT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-33.34%
COGT TTM EBITDA YoY % (-15.42% → -33.34%)
High-resolution chart · PNG

COGT ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Cogent Biosciences Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-33.3364%
-32.0269%
-29.5517%
-20.8969%
-25.0894%
-27.2925%
-33.1985%
-36.9846%
-48.087%
-45.9019%
-39.4271%
-43.0479%
-37.9602%
-56.8762%
-85.0146%
-103.3516%
-114.5845%
-119.1972%
-111.7446%
-190.5958%
-130.2309%
-64.6301%
-12.5049%
50.4607%
44.8013%
35.3132%
10.3813%
-27.3874%
-37.0933%
-50.7037%
-37.2483%
-17.5901%
-15.4217%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.